Infliximab is Formulary, Restricted to patients meeting criteria:

• • Infliximab may be an adjunctive treatment option for treating hospitalized patients with acute flares of ulcerative colitis or Crohn's,  refractory to IV corticosteroids. Corticosteroid-refractory is defined as having little or no improvement within 72 hours of starting IV corticosteroids.
    • OR
  • Patients with severe immune related adverse events (other than hepatitis), secondary to immunotherapy, who are not responsive to corticosteroids within 48-72 hours.

See Infliximab Administration Policy: 900.4069

Infusion requires an in-line 0.22 micron filter. See Filter Recommendations for IV Medications

• Micromedex
• CareNotes
• UpToDate
• Facts & Comparisons
• MedLinePlus (Patient Information)